Tuesday 29 November 2016

Remote Patient Monitoring Devices Market To Gain From Augmented Usage In Cancer And Cardiovascular Diseases Till 2025: Grand View Research, Inc.



Global remote patient monitoring devices market is expected to reach USD 1.9 billion by 2025, according to a new report by Grand View Research Inc. Remote patient monitoring devices, due to their capability to monitor various chronic conditions such as diabetes, cardiovascular conditions, and cancer are expected to witness substantial growth over the forecast period.
Increasing incidences of cardiovascular diseases, rising geriatric population base and the growing demand for independent and healthy living by them are high impact rendering drivers for remote patient monitoring devices market. Moreover, improving healthcare infrastructure, increasing post-acute care management and growing focus of key market players on emerging economies is also expected to fuel the growth of this market.
Rapid technological advancement occurring in remote patient monitoring devices market is expected to lead towards availability of better option for healthcare practitioners and the patients, thereby promoting the growth of remote patient monitoring devices market. Remote patient monitoring devices encompass a wide array of technologies designed to manage, evaluate, notify, intervene, and modify the treatment plan as required.
The remote patient monitoring devices are most commonly used to slow the progression of chronic disorders and enhance recovery after getting discharged from an acute care unit. Remote patient monitoring technologies also alerts caregivers for prompt intervention through any vulnerable condition.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/remote-patient-monitoring-devices-market

Further key findings from the study suggest:
·         Heart rate monitors are identified as the most lucrative sub-segment with a significant growth rate of over the forecast period owing to increasing incidences of cardiac related conditions globally.
·         Heart rate monitor segment accounted for a significant market share in 2014. The rise in demand for home healthcare and independent living by geriatric population are high impact rendering drivers for remote patient monitoring devices market segment.
·         North America accounted for more than 40% of the remote patient monitoring devices market in 2014 on account of the high demand for technologically advanced products. Presence of sophisticated healthcare infrastructure along with high awareness level of the patients regarding their health has led to the growth of overall remote patient monitoring devices market.
·         Asia Pacific market is expected to have high growth potential for remote patient monitoring devices due to the presence of large unmet needs in the emerging economies such as China and India. Presence of suitable government initiatives to curb the deteriorating environmental conditions and enhancing healthcare infrastructure in Japan and Australia are also expected to attribute to the remote patient monitoring devices market’s attractiveness.
·         Key players of the remote patient monitoring devices market include Philips, Honeywell, American Telecare, Roche, Philips Healthcare, Bosch, Biotronik, Intel, Welch Allyn, Health anywhere Inc, Johnson & Johnson and Covidien Plc.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global remote patient monitoring devices market on the basis of products, application, end-use and region:
Global Remote Patient Monitoring Devices Product Outlook (Revenue, USD Million, 2012 - 2022)
·         Vital Sign Monitors
o    Blood Pressure Monitor
o    Pulse Oximeters
o    Heart Rate Monitor (ECG)
o    Temperature Monitor
o    Respiratory Rate Monitor
o    Brain Monitor (EEG)
·         Special
o    Anesthesia Monitor
o    Blood Glucose Monitor
o    Cardiac Rhythm Monitor
o    Respiratory Monitor
o    Fetal heart Monitor
o    Prothrombin Monitor
o    Multi Parameter Monitor (MPM)
o    Others (Ventilators, Infusion Pumps and Others)
Global Remote Patient Monitoring Devices Application Outlook (Revenue, USD Million, 2012 - 2022)
·         Cancer Treatment
·         Cardiovascular Diseases Treatment
·         Diabetes Treatment
·         Sleep Disorder Treatment
·         Weight Management and Fitness Monitoring
Global Remote Patient Monitoring Devices End-Use Outlook (Revenue, USD Million, 2012 - 2022)
·         Hospital based patients
·         Ambulatory Patients
·         Home Healthcare
Global Remote Patient Monitoring Devices Regional Outlook (Revenue, USD Million, 2012 - 2022)
·         North America
o    U.S.
o    Rest of North America
·         Europe
o    Germany
o    UK
o    Rest of Europe
·         Asia Pacific
o    Japan
o    China
o    India
o    Rest of Asia Pacific
·         Latin America
o    Brazil
o    Mexico
o    Rest of Latin America
·         Middle East and Africa (MEA)
o    South Africa
o    Rest of Middle East and Africa

For press release of this report - http://www.grandviewresearch.com/press-release/global-remote-patient-monitoring-devices-market

Transfection Reagent And Equipment Market Size Was Valued At USD 616.59 Million In 2014 And Is Expected To Reach $1,086.02 Million By 2022: Grand View Research, Inc.



The global transfection reagent & equipment market is expected to reach USD 1,086.02 million by 2022, according to a new report by Grand View Research, Inc. This anticipated growth in demand can be attributed to growing need for protein production, biopharmaceutical development, and vaccine research and development; all of which rely heavily on cytological R&D and transfection.
Larger market entities are also involved in efforts to expand their market presence in the Asia Pacific region and tap the high potential for growth available. Expected growth of genomic and proteomic research is also a strong factor which will positively impact the growth in demand for transfection.


U.S. Transfection Reagent & Equipment Market revenue by method, 2012-2022, (USD Million)

 U.S. Transfection Reagent & Equipment Market 
 
Further key findings from the study suggest:
  • Out of both the broad segments of products available, transfection equipment accounted for a larger share of the market in 2014 and owing to their inherently more expensive nature than reagents are expected to maintain this dominant position over the forecast period.
  • The market space for transfection has an abundant number of methods to achieve the aforementioned. However, these vary significantly in usage rates and implementation complexities. Electroporation and liposomal transfection combine to account for over 30% of the market owing to high associated advantages.
  • Growing applications of transfection techniques poise the segments in a strong position and estimated valuation clocks usage of transfection in gene expression at over USD 130 million and for protein production at over USD 110 million for the year 2014.
  • North America was observed to be responsible for the largest share of revenue in 2014 which amounted to a little over USD 240 million. The United States houses the headquarters of operations for a number of market leaders and a number of established research and development. This provides a strong platform for development, manufacture & distribution various vaccines, and biopharmaceuticals which fuels market growth.
  • However, it is Asia Pacific region which is anticipated to witness significant growth over the forecast period in various segments owing to considerable growth of cytological research, development of biosimilar drugs and high potential of growth in these relatively untapped regional segments.
  • Asia Pacific is expected to grow at a significant rate over the forecast period in terms of increasing production and development of vaccines, drugs, and new biologics. Supportive government initiatives pertaining to increasing investments by manufacturers and governments in biopharmaceutical manufacturing and high untapped market opportunities are the important factors accounting for the expected growth of market in this region over the forecast period.
  • Promega, Roche and Thermo Fisher owned Life Technologies accounted for the largest of revenue in 2014 and are involved in new product development for expansion of their portfolios over the forecast period. Acquisition of smaller players is also expected over the forecast period by larger companies
  • Key market players in the Transfection Reagent & Equipment Market include BTX (Harvards Apparatus Inc.), SignaGen Laboratories, OriGene Technologies, EMD Millipore, VWR International LLC, Bio-Rad Laboratories Inc., Mirus Bio LLC, F. Hoffman-La Roche AG, Lonza AG, Life Technologies (Thermo Fisher), and Promega Corporation. 
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented Transfection Reagent & Equipment Market on the basis of product, method, application, and region:
Global Transfection reagents & equipment Product Outlook (Revenue, USD Million, 2012 – 2022)
  • Reagents
  • Equipment
Global Transfection reagents & equipment Method Outlook (Revenue, USD Million, 2012 – 2022)
  • Electroporation
  • Liposomes
  • Particle Bombardment
  • Microinjection
  • Adenoviral vectors
  • Direct microinjection
  • Calcium phosphate
  • DEAE-dextran
  • Magnetic beads
  • Activated Dendrimers
  • Laserfection
Global Transfection reagents & equipment Application Outlook (Revenue, USD Million, 2012 – 2022)
  • Gene expression studies
  • Protein production
  • Transgenic delivery
  • Cancer research
  • Biomedical research
Transfection reagents & equipment Regional Outlook (Revenue, USD Million, 2012 – 2022)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • MEA
    • South Africa


Monday 28 November 2016

Wearable Medical Device Market To Represent USD 27.8 Billion Opportunity Globally by 2022: Grand View Research, Inc.



Global Wearable Medical Device Market is expected to reach USD 27.8 billion by 2022, according to a new report by Grand View Research, Inc. Rising prevalence of conditions such as obesity and hypertension, as a result of sedentary lifestyle is anticipated to boost the demand for wearable medical devices. Moreover, increasing health awareness is further expected to augment the demand for these devices.
Additionally, growing incidences of chronic conditions, such as diabetes, which require round-the-clock monitoring, are expected to increase the demand for wearable technology. Technological innovation is projected to be vital for growth of this industry over the forecast period. Smart watches, smart bands, and smart clothing are anticipated to be the key areas for development. Increasing penetration of smart cellular phones is expected to assist growth of this technology. However, patient privacy and security concerns along with complexity in engineering are expected to impede growth of the industry.


Further key findings from the study suggest:
  • Diagnostic wearable medical devices held substantial share in 2014 owing to increasing usage in remote patient monitoring as well as home healthcare
  • Therapeutic wearable devices are anticipated to exhibit remunerative growth over the forecast period. Increasing penetration of products, such as insulin monitors, is assisting the growth of wearable equipment.
  • Diagnostic devices such as vital sign monitors are expected to witness lucrative growth over the forecast period. Rising incidences of chronic diseases are expected to boost the demand for this equipment.
  • Wearable medical devices have applications in sports & fitness monitoring, home healthcare, and remote patient monitoring. Home healthcare held significant shares of around 50.0% in 2014. Simplified usage of this equipment along with ability to synchronize with cellular phones as well as tablet devices assisted the growth of this segment.
  • On the contrary, remote patient monitoring is projected to exhibit growth rate of over 25.00% in the next seven years. Increasing geriatric population base coupled with demand for continuous monitoring is expected to fuel the growth.
  • Strap/clip/bracelet or watches held substantial shares of around 40.0% in 2014, and is expected to grow at a lucrative rate over the forecast period. Simplified engineering, aesthetically appealing products, and synchronization with mobile application are anticipated to drive this segment’s growth.
  • North America dominated the overall market with approximately 40.0% of shares. This can be attributed to increasing per capita income as well as rising healthcare spending, and advanced healthcare infrastructure and presence of OEM in this region.
  • Asia Pacific is projected to grow with a rapid rate of around 32.0% over the forecast period. Economic development coupled with improving healthcare systems is expected to help the industry grow in this region.
  • Key companies of the wearable medical devices industry include Fitbit Inc., Garmin, Vital Connect, Omron Corp., Sotera Wireless, Jawbone, Pebble Technology Corp., Basis Science, Inc., Withings, Intelesens Ltd., Covidien Plc, LifeWatch AG, Polar Electro, Philips Electronics, and Everist Genomics 
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global Wearable Medical Device Market on the basis of products and region:
Global Wearable Medical Devices Product Outlook (USD million), 2012 – 2022
  • Diagnostic devices
    • Vital sign monitors
      • Heart rate monitors
      • Activity monitors
      • Electrocardiographs
      • Pulse oximeters
      • Spirometers
      • Blood pressure monitors
      • Other devices
    • Sleep monitoring devices
      • Sleep trackers
      • Wrist actigraphs
      • Polysomnographs
      • Other devices
    • Electrocardiographs Fetal & Obstetric Devices
    • Neuromonitoring devices
      • Electroencephalographs (EEG)
      • Electromyographs (EMG)
      • Other devices
  • Therapeutic devices
    • Pain management device
      • Neurostimulation device
      • Other devices
    • Insulin monitoring device
      • Insulin pumps
      • Other devices
    • Rehabilitation device
      • Accelerometers
      • Sensing devices
      • Ultrasound platforms
      • Others
    • Respiratory therapy device
      • Ventilators
      • PAP
      • Portable oxygen concentrators
      • Other devices
Global Wearable Medical Devices Application Outlook (USD million), 2012 – 2022
  • Sports & Faintness
  • Remote Patient Monitoring
  • Home healthcare
Global Wearable Medical Devices Site Outlook (USD million), 2012 – 2022
  • Handheld
  • Headband
  • Strap, clip, bracelet and watches
  • Shoe sensors
  • Others
Wearable Medical Devices Region Outlook (USD million), 2012 – 2020
  • North America
    • U.S.
    • Mexico
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia